Skin climacteric aging and hormone replacement therapy

Journal of Cosmetic Dermatology

Volumn 5, Issue 1, 2006, Pages 3-8

  Quatresooz, Pascale ^a   Pierard Franchimont C ^a   Gaspard, U ^a   Piérard, Gérald E ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Aging; Estrogen; Hormone replacement therapy; Menopause; Sex steroid

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; COLLAGEN; COSMETIC; ESTROGEN DERIVATIVE; ESTROGEN RECEPTOR; FINASTERIDE; GESTAGEN; GROWTH HORMONE; NEUROTRANSMITTER; PROGESTERONE DERIVATIVE; RETINOIC ACID; SEX HORMONE; TIBOLONE;

AGING; ALOPECIA; BONE DENSITY; BONE MASS; CHEMICAL ANALYSIS; CLIMACTERIUM; DERMATOLOGY; DERMIS; DISEASE EXACERBATION; ELASTICITY; ENDOMETRIUM HYPERPLASIA; ENVIRONMENTAL FACTOR; EPIDERMIS; ESTROGEN DEFICIENCY; FEMALE; FRAGILITY FRACTURE; HAIR GROWTH; HAIR LOSS; HORMONE SUBSTITUTION; HUMAN; HYPERTRICHOSIS; MENOPAUSE; MICROCIRCULATION; PRIORITY JOURNAL; REVIEW; SEBUM SECRETION; SKIN BLOOD VESSEL; SKIN DISEASE; SKINFOLD THICKNESS; SUN EXPOSURE; SUNLIGHT; THERMOREGULATION; WRINKLE; XEROSIS;

BIOMECHANICS; CLIMACTERIC; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; MENOPAUSE; MICROCIRCULATION; MIDDLE AGED; SKIN; SKIN AGING;

EID: 33645557318     PISSN: 14732130     EISSN: 14732165     Source Type: Journal    
DOI: 10.1111/j.1473-2165.2006.00215.x     Document Type: Review

References (65)

1. Grady D, Herrington D, Bittner V, et al. Cardiovascular disease outcomes during 6.8 years of hormone therapy. Heart and estrogen/progestin replacement study follow-up (HERS II). JAMA 2002; 288: 49-57.
2. Writing Group for the Women's Health Initiative Investigations. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. JAMA 2002; 288: 321-33.
3. Viscoli CM, Brass LM, Kerman WN, Sarrel PM, Suissa S, Horwitz RI. A clinical trial of estrogen replacement therapy after ischemic stroke. N Engl J Med 2001; 345: 1243-9.
4. The Women's Health Initiative Steering Committee. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy. JAMA 2004; 291: 1701-12.
5. The American College of Obstetricians and Gynecologists. Hormone therapy. Obstet Gynecol 2004; 104 (S4): S1-131.
6. Scarabin PY, Oger E, Plu Bureau G. Differential association of oral and transdermal estrogen replacement therapy with venous thromboembolism risk. Lancet 2003; 362: 428-32.
7. Fournier A, Berrino F, Riboli E, Avenel V, Clavel-Chapelon F. Breast cancer risk in relation to different types of hormone replacement therapy in the E3N-EPIC cohort. Int J Cancer 2004; 114 (3): 448-54.
8. Bolognia JL. Aging skin. Am J Med 1995; 98: 99-103.
9. Piérard GE. The quandary of climacteric skin aging. Dermatology 1996; 193: 273-4.
10. Piérard GE. Aging across the life span: Time to think again. J Cosmet Dermatol 2004; 3: 50-3.
11. Beauregard S, Gilchrest BA. A survey of skin problems and skin care regimens in the elderly. Arch Dermatol 1987; 123: 1638-43.
12. Brincat M, Moniz CJ, Studd JW, et al. Long-term effects of the menopause and sex hormones on skin thickness. Br J Obstet Gynaecol 1985;92: 256-9.
13. Brincat M, Kabalan S, Studd JW, Moniz CF, de Trafford J, Montgomery J. A study of the decrease of skin collagen content, skin thickness, and bone mass in the postmenopausal women. Obstet Gynecol 1987; 70: 840-5.
14. Affinito P, Palomba S, Sorrentino C, et al. Effects of postmenopausal hypoestrogenism of skin collagen. Maturitas 1999; 33: 139-47.
15. Schmidt JB, Lindmaier A, Spona J. Hormone receptors in pubic skin of premenopausal and postmenopausal females. Gynecol Obstet Invest 1990; 30: 97-100.
16. Sawaya ME, Penneys NS. Immunohistochemical distribution of aromatase and 3B-hydroxysteroid dehydrogenase in human hair follicle and sebaceous gland. J Cutan Pathol 1992; 19: 309-14.
17. Simpson ER, Mahendroo MS, Means GD, et al. Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis. Endocr Rev 1994; 15: 342-55.
18. Agarwal VR, Ashanullah CI, Simpson ER, Bulun SE. Alternatively spliced transcripts of the aromatase cytochrome P450 (CYP19) gene in adipose tissue of women. J Clin Endocrinol Metab 1997; 82: 70-4.
19. Callens A, Vaillant L, Lecomte P, Berson M, Gall Y, Lorette F. Does hormonal skin aging exist? A study of the influence of different hormone therapy regiments on the skin of postmenopausal women using non-invasive measurement techniques. Dermatology 1996; 193: 289-94.
20. Dunn LB, Damesyn M, Moore AA, Reuben DB, Greendale GA. Does estrogen prevent skin aging? Results from the first National Health and Nutrition Examination Survey (NHANES I). Arch Dermatol 1997; 133: 339-42.
21. Raine-Fenning NJ, Sant RA, Brincat MP. HRT in the new millennium. Contemp. Clin Gynecol Obstet 2001; 1: 7-23.
22. Raine-Fenning NJ, Brincat M, Muscat-Baron Y. Skin aging and menopause: implications for treatment. Am J Clin Dermatol 2003; 4: 371-8.
23. Brincat M, Versi E, O'Dowd T, et al. Skin collagen changes in post-menopausal women receiving oestradiol gel. Maturitas 1987; 9: 1-5.
24. Brincat M, Versi E, Moniz CF, Magos A, de Trafford J, Studd JW. Skin collagen changes in postmenopausal women receiving different regimens of estrogen therapy. Obstet Gynecol 1987; 70: 123-7.
25. Savvas M, Bishop J, Laurent G, Watson N, Studd J. Type III collagen content in the skin of postmenopausal women receiving oestradiol and testosterone implants. Br J Obstet Gynaecol 1993; 100: 154-6.
26. Maheux R, Naud F, Rioux M, et al. A randomized, double-blind, placebo-controlled study on the effect of conjugated estrogens on skin thickness. Am J Obstet Gynecol 1994; 170: 642-69.
27. Varila E, Rantala I, Oikarinen A, et al. The effect of topical oestradiol on skin collagen of postmenopausal women. Br J Obstet Gynaecol 1995; 102: 985-9.
28. Schmidt JB, Binder M, Demschik G, Biegmayer C, Reiner A. Treatment of skin aging with topical estrogens. Int J Dermatol 1996; 35: 669-74.
29. Cortes-Gallegos V, Villanueva GL, Sojo-Aranda I, Santa Cruz FJ. Inverted skin changes induced by estrogen and estrogen/glucocorticoid on aging dermis. Gynecol Endocrinol 1996; 10: 125-8.
30. Sauerbronn AV, Fonseca AM, Bagnoli VR, Saldiva PH, Pinotti JA. The effect of systemic hormonal replacement therapy on the skin of postmenopausal women. Int J Gynaecol Obstet 2000; 68: 35-41.
31. Sator PG, Schmidt JB, Sator MO, Huber JC, Honigsmann H. The influence of hormone replacement therapy on skin aging: A pilot study. Maturitas 2001; 39: 43-55.
32. Varila E, Sievanen H, Vuori I, Oksanen H, Punnonen R. Limited value of ultrasound measured skin thickness in predicting bone mineral density in peri- and postmenopausal women. Maturitas 1995; 21: 45-9.
33. Haapasaari KM, Raudaskoski T, Kallioinen M, et al. Systemic therapy with estrogen or estrogen with progestin has no effect on skin collagen in postmenopausal women. Maturitas 1997; 27: 153-62.
34. Oikarinen A. Systemic estrogens have no conclusive beneficial effect on human skin connective tissue. Acta Obstet Gynecol Scand 2000; 79: 250-4.
35. Henry F, Piérard-Franchimont C, Cauwenbergh G, Pierard GE. Age-related changes in facial skin contours and rheology. J Am Geriatr Soc 1997; 45: 220-2.
36. Piérard GE, Henry F, Castelli D, Ries G. Aging and rheological properties of facial skin in women. Gerontology 1998; 44: 159-61.
37. Hermanns-LêT, Uhoda I, Smitz S, Piérard GE. Skin tensile properties revisited during aging. Where now, where next? J Cosmet Dermatol 2004; 3: 35-40.
38. Piérard GE, Uhoda I, Piérard-Franchimont C. From skin microrelief to wrinkles. An area ripe for investigations. J Cosmet Dermatol 2003; 2: 21-8.
39. Piérard GE, Letawe C, Dowlati A, Piérard-Franchimont C. Effect of hormone replacement therapy for menopause on the mechanical properties of skin. J Am Geriatr Soc 1995; 43: 662-5.
40. Piérard-Franchimont C, Cornil F, Dehavay J, Letot B, Deleixhe-Mauhin F, Piérard GE. Climacteric skin aging of the face. A prospective longitudinal intent-to-treat trial on the effect of oral hormone replacement therapy. Maturitas 1999; 32: 87-93.
41. Piérard GE, Henry F, Piérard-Franchimont C. Comparative effect of short-term topical tretinoin and glycolic acid on mechanical properties of photodamaged facial skin in HRT-treated menopausal women. Maturitas 1996; 23: 273-7.
42. Castelo-Branco C, Figueras F, Martinez de Osaba MJ, Vanrell JA. Facial wrinkling in postmenopausal women. Effects of smoking status and hormone replacement therapy. Maturitas 1998; 29: 75-86.
43. Nilas L, Christiansen C. Rates of bone loss in normal women: Evidence of accelerated trabecular bone loss after the menopause. Eur J Clin Invest 1988; 18: 529-34.
44. Chappard D, Alexandre C, Robert JM, Riffat G. Relationships between bone and skin atrophies during aging. Acta Anat 1991; 141: 239-44.
45. Castello-Branco C, Pons F, Gratacos E, Fortuny A, Vanrell JA, Gonzales-Merlo J. Relationship between skin collagen and bone changes during aging. Maturitas 1994; 18: 199-206.
46. Affinito P, Palomba S, Sorrentino C, et al. Effects of postmenopausal hypoestrogenism on skin collagen. Maturitas 1999; 33: 239-47.
47. Shah MG, Maibach HI. Estrogen and skin: An overview. Am J Clin Dermatol 2001; 2: 143-50.
48. Brincat M, Moniz CF, Kabalan S, et al. Decline in skin collagen content and metacarpal index after the menopause and its prevention with sex hormone replacement. Br J Obstet Gynaecol 1987; 94: 126-9.
49. Piérard GE, Vanderplaetsen S, Piérard-Franchimont C. Comparative effect of hormone replacement therapy on bone mass density and skin tensile properties. Maturitas 2001; 40: 221-7.
50. Piérard GE, Piérard-Franchimont C, Vanderplaetsen S, Franchimont N, Gaspard U, Malaise M. Relationships between bone mass density and tensile strength of the skin in women. Eur J Clin Invest 2001; 31: 731-5.
51. Henry F, Quatresooz P, Valverde-Lopez JC, Piérard GE. Blood vessel changes during pregnancy. A review. J Cosmet Dermatol, in press.
52. Haenggi W, Linder HR, Birkhauser MH, Schneider H. Microscopic findings of the nail-fold capillaries-dependence on menopausal status and hormone replacement therapy. Maturitas 1995; 22: 37-46.
53. Brooks-Asplung EM, Kenney WL. Chronic hormone replacement therapy does not alter resting or maximal skin blood flow. J Appl Physiol 1998; 85: 505-10.
54. Brooks EM, Morgan AL, Pierzga JM, et al. Chronic hormone replacement therapy alters thermoregulatory and vasomotor function in postmenopausal women. J Appl Physiol 1997; 83: 477-84.
55. Ginsburg J, Hardiman P, O'Reilly B. Peripheral blood flow in menopausal women who have hot flushes and in those who do not. Br Med J 1989; 298: 1488-90.
56. Brincat M, de Trafford JC, Lafferty K, Studd JW. Peripheral vasomotor control and menopausal flushing. A preliminary report. Br J Obstet Gynaecol 1984; 91: 1107-10.
57. Margolis DJ, Knauss J, Bilker W. Hormone replacement therapy and prevention of pressure ulcers and venous leg ulcers. Lancet 2002; 359: 675-7.
58. Ashcroft GS, Greenwell-Wild T, Horan MA, Wahl SM, Ferguson MW. Topical estrogen accelerates cutaneous wound healing in aged humans associated with an altered inflammatory response. Am J Pathol 1999; 155: 1137-46.
59. Piérard-Franchimont C, Letawe C, Goffin V, Piérard GE. Skin water-holding capacity and transdermal estrogen therapy for menopause: A pilot study. Maturitas 1995; 22: 151-4.
60. Paquet F, Piérard-Franchimont C, Fumal I, Goffin V, Paye MGE, Piérard GE. Sensitive skin at menopause: Dew point and electrometric properties of the stratum corneum. Maturitas 1998; 28: 221-7.
61. Quatresooz P, Petit L, Uhoda I, Piérard-Franchimont C, Piérard GE. Mosaic subclinical melanoderma. An Achilles heel for UV-related epidermal carcinogenesis. Int J Oncol 2004; 25: 1763-8.
62. Tosti A, Piraccini BM, Iorizzo M, Misciali C. Frontal fibrosing alopecia in postmenopausal women. J Am Acad Dermatol 2005; 25: 55-60.
63. Dören M. Differential effects on the androgen status of postmenopausal women treated with tibolone and continuous combined estradiol and norethindrone acetate replacement therapy. Fertil Steril 2001; 75: 554-9.
64. Roux C. Randomised, double-masked, 2 years comparison of tibolone with 17β estradiol and norethindrone acetate in preventing postmenopausal bone loss. Osteoporosis Int 2002; 13: 241-8.
65. Piérard-Franchimont C, Piérard GE. Post-menopausal aging of the sebaceous follicle. A comparison between women receiving hormone replacement therapy or not. Dermatology 2002; 204: 17-22.